Comparison of triple-drug transcatheter arterial chemoembolization (TACE) with single-drug tace using doxorubicin-eluting beads: Long-term survival in 313 patients
American Journal of Roentgenology Oct 20, 2017
Gomes AS, et al. - A retrospective study was performed to compare survival outcomes in 313 patients with unresectable hepatocellular carcinoma (HCC) treated with two different transcatheter arterial chemoembolization (TACE) regimens: triple-drug TACE or single-drug TACE utilizing drug-eluting beads. Based on these outcomes, no significant survival difference was observed in patients with unresectable HCC treated with triple-drug TACE compared with single-drug TACE utilizing doxorubicin-eluting beads.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
